Table 3.
Correlation of FCA Severity Score (FCASS) with acute serum levels of inflammatory markers measured in the VIPS study*
Baseline FCASS | Maximum FCASS | |||
---|---|---|---|---|
n=36 |
n=36** |
|||
Serum Inflammatory Marker | Spearman’s rho | p-value | Spearman’s rho | p-value |
hsCRP | 0.35 | 0.036 | 0.47 | 0.004 |
MPO | 0.30 | 0.08 | 0.28 | 0.10 |
SAA | 0.20 | 0.24 | 0.27 | 0.11 |
TNF-α | −0.05 | 0.75 | −0.16 | 0.34 |
hsCRP=human C-reactive protein; SAA=serum amyloid A; MPO=myeloperoxidase; TNF-α=tumor necrosis factor alpha
Inflammatory markers were not available for 5 of the 41 FCA patients.
For those with no follow-up imaging, the baseline score was considered to be the maximum score.